Cite

HARVARD Citation

    Nijman, T. et al. (2019). Cost effectiveness of nifedipine compared with atosiban in the treatment of threatened preterm birth (APOSTEL III trial). BJOG. pp. 875-883. [Online]. 
  
Back to record